Gross Margin
25.24%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 21.51%.Updated Aug 18, 2026Profit Margin
-1.10%vs Specialty Chemicals peers Updated Aug 18, 2026Operating Margin
8.80%vs Specialty Chemicals peers Updated Aug 18, 2026Return on Assets (TTM)
1.52%vs Specialty Chemicals peers Updated Aug 18, 2026Return on Equity (TTM)
-1.32%vs Specialty Chemicals peers Updated Aug 18, 2026Revenue (TTM)
5.22TKRW3.70B · vs all stocks (USD) Updated Aug 18, 2026Revenue per Share (TTM)
230.95KKRWUpdated Aug 18, 2026Quarterly Revenue Growth
-7.50%vs Specialty Chemicals peers Updated Aug 18, 2026Gross Profit (TTM)
1.12TKRW795.52M · vs all stocks (USD) Updated Aug 18, 2026EBITDA (TTM)
806.08BKRW570.74M · vs all stocks (USD) Updated Aug 18, 2026Net Income (TTM)
-51.35BKRW-36.36M · vs all stocks (USD) Updated Aug 18, 2026Operating Cash Flow (TTM)
709.64BKRW502.45M · vs all stocks (USD) Updated Aug 18, 2026Levered Free Cash Flow (TTM)
322.83BKRW228.58M · vs all stocks (USD) Updated Aug 18, 20265-Year Average Dividend Yield
2.70%Updated Aug 18, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 18, 2026Minority Interest (Equity)
899.53BKRWFY2025 · Dec 31, 2025Revenue
5.33TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
4.20TKRWFY2025 · Dec 31, 2025Gross Profit
1.13TKRWFY2025 · Dec 31, 2025Operating Income
298.62BKRW211.43M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-16.78BKRWFY2025 · Dec 31, 2025Income Tax Expense
79.52BKRWFY2025 · Dec 31, 2025Net Income
-96.30BKRWFY2025 · Dec 31, 2025EBIT
284.68BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
798.05BKRWFY2025 · Dec 31, 2025Research & Development
102.28BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
392.98BKRWFY2025 · Dec 31, 2025Other Operating Expenses
248.00MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
31.96BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
301.46BKRWFY2025 · Dec 31, 2025EPS (Basic)
-3.98KKRWFY2025 · Dec 31, 2025EPS (Diluted)
-3.98KKRWFY2025 · Dec 31, 2025Basic Shares Outstanding
22.08MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
22.08MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-96.30BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
8.29BKRWFY2025 · Dec 31, 2025Operating Cash Flow
412.63BKRWFY2025 · Dec 31, 2025Free Cash Flow
182.15BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.15TKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-96.30BKRWFY2025 · Dec 31, 2025Other Non-cash Items
264.39BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
100.17BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
144.37BKRWFY2025 · Dec 31, 2025Capital Expenditures
-230.48BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-5.83BKRWFY2025 · Dec 31, 2025Net Acquisitions
127.84BKRWFY2025 · Dec 31, 2025Purchase of Investments
-105.71BKRWFY2025 · Dec 31, 2025Sale of Investments
214.87BKRWFY2025 · Dec 31, 2025Other Investing Activity
-4.84BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
1.69BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
803.66BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-2.29TKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-543.95BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-39.80BKRWFY2025 · Dec 31, 2025Other Financing Charges
26.30BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.04TKRWFY2025 · Dec 31, 2025